1. Home
  2. CDNA vs PNTG Comparison

CDNA vs PNTG Comparison

Compare CDNA & PNTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$19.16

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo The Pennant Group Inc.

PNTG

The Pennant Group Inc.

HOLD

Current Price

$27.82

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDNA
PNTG
Founded
1998
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Medical/Nursing Services
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
CDNA
PNTG
Price
$19.16
$27.82
Analyst Decision
Buy
Strong Buy
Analyst Count
7
7
Target Price
$26.67
$35.33
AVG Volume (30 Days)
750.2K
218.0K
Earning Date
11-04-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
10.47
EPS
1.22
0.75
Revenue
$357,998,000.00
$847,274,000.00
Revenue This Year
$14.11
$36.42
Revenue Next Year
$11.75
$23.99
P/E Ratio
$15.51
$37.44
Revenue Growth
14.46
29.89
52 Week Low
$10.96
$21.18
52 Week High
$25.95
$30.46

Technical Indicators

Market Signals
Indicator
CDNA
PNTG
Relative Strength Index (RSI) 54.20 41.70
Support Level $19.01 $28.99
Resistance Level $20.61 $29.91
Average True Range (ATR) 0.71 0.67
MACD -0.22 -0.31
Stochastic Oscillator 18.43 9.21

Price Performance

Historical Comparison
CDNA
PNTG

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About PNTG The Pennant Group Inc.

Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.

Share on Social Networks: